Nascent Pharma Holdings, Inc.

OTC: NASC · Healthcare · Drug Manufacturers - Specialty & Generic

PublicHQ Hicksville, NY · NassauCIK 0002042814Reports USD

#1 of 1,418 Healthcare companies by revenue

EA Score

——

FH —DQ —GM —SS 40

v0.1 · 5/100 weight · pillars only

↑ listing tenure, Piotroski F · ↓ Altman-Z, market scale

Methodology →

Revenue TTM

$1.0M

Rev growth YoY (TTM)

-57.7%

Net income (FY)

—

Employees

as of 2026-08-26

Market cap

$515.7k

as of 2026-08-26

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

No filed financials — private or non-XBRL filer.

Revenue by segment

Filed disclosures · FY2023

By product

Service100%

By geography

Not disclosed.

The read

What is Nascent Pharma Holdings, Inc.’s financial profile?

Nascent Pharma Holdings, Inc. has no structured financials on file — private or non-XBRL filer.

Peers · Healthcare

ZyVersa Therapeutics, Inc.——XORTX Therapeutics Inc.——China Health Management Corp.——Stella Diagnostics Inc.——Solanbridge Group, Inc.——CaliPharms, Inc.——

Neighbors

Nassau →

Broadridge Financial Solutions, Inc.$6.9B77B+Kimco Realty Corporation$2.1B69B Flagstar Financial, Inc.$27.0M41D Veeco Instruments Inc.$664.3M71B Getty Realty Corp.$221.7M78B+Global Industrial Co$1.4B75B+

Key facts

CEOMarco Alfonsi

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

HeadquartersHicksville, NY

ExchangeOTC: NASC

Employees12

IPO date2012-08-03

Latest filings

No filings loaded.

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.